Mycoplasma Testing Market:
Growth opportunities in the mycoplasma testing market look promising over the next six years. This is mainly due to the increasing prevalence of infectious and chronic ailments, including cancer and AIDS, and the stimulating aging population.
Mycoplasma Testing Market Dynamics (including market size, share, trends, forecast, growth, forecast, and industry analysis)
Key Drivers
The surging incidences of infectious and chronic diseases, which include cancer, HIV/ AIDS, and COVID-19, accelerating geriatric population, along with altering consumer’s lifestyle, are the prominent factors driving the growth of the global mycoplasma testing market. The growing occurrence of coronavirus infections and the growth in the demand to discover and diagnose the number of cases, and the retaliation of antibodies have strengthened the mycoplasma testing market size. For example, in accordance with the Worldometer Information, approximately 140 million people in April were infected by covid-19, with 3 million deaths throughout the world, resulting in robust demand for the identification of the antibody-antigen test to fight against the infection caused by the coronavirus. Also, this testing is largely used to test co-infection of other pathogens, which includes mycoplasma pneumonia in patients with COVID-19. However, the excessive investment requires high disbursement, and the market is incorporated mainly by huge market players, which may hinder the mycoplasma testing market share.
Product Segment Drivers
Based on product, kits & reagents are projected to witness a higher CAGR during the forecast period. This is owing to the growing demand for substantial research and development in the biopharmaceutical & pharmaceutical industry. For example, as per the Pharmaceutical Research and Manufacturers Association (PhRMA), the United States accounts for more than half of the world’s R&D in pharmaceuticals, equivalent to US$ 75 billion. Also, the biopharmaceutical industry counted for almost US$ 1.3 trillion for the economic output of the United States.
Regional Drivers
Based on the regional coverage, North America is expected to lead the market over the forecast period. This is primarily attributed to the prevalence of major players, expanding R&D activities, and the rising occurrence of chronic and infectious ailments like cancer and coronavirus with the boost in investment by prominent companies. For example, Pfizer, in 2019, invested US$ 500 million for developing a manufacturing facility in Sanford, North Carolina. The U.S. Department of Health and Human Services (HHS), in 2020, collaborated with private players in the United States to enlarge U.S.-Based Pharmaceutical Manufacturing capacity for COVID-19 response.
Mycoplasma Testing Market’s leading Manufacturers:
- Boeing
- Biotools B & M Labs, S.A.
- InvivoGen
- Minerva Biolabs GmbH
- ROCHE DIAGNOSTICS
- CHARLES RIVER LABORATORIES
- Merck KGaA
- CREATIVE BIOARRAY
- Agilent Technologies
- SARTORIUS AG
- Bionique Testing Laboratories
- Lonza Group Ltd.
- THERMO FISHER SCIENTIFIC, INC
Mycoplasma Testing Market Segmentation:
Segmentation by Product
- Kits & Reagents
- PCR Assay
- Nucleic Acid Detection Kits (NAT)
- Elimination Kits
- Standards & Controls
- Stains
- Others
- Instruments
- Services
- Others
Segmentation by Technology
- PCR
- ELISA
- Direct Assay
- Indirect Assay
- Enzymatic Methods
- Microbial Culture Techniques
- Others
Segmentation by Application
- Virus Testing
- Cell Line Testing
- End of Production Cells Testing
- Others
Segmentation by Region:
- North America
- United States of America
- Canada
- Asia Pacific
- China
- Japan
- India
- Rest of APAC
- Europe
- United Kingdom
- Germany
- France
- Spain
- Rest of Europe
- RoW
- Brazil
- South Africa
- Saudi Arabia
- UAE
- Rest of the world (remaining countries of the LAMEA region)
About GMI Research
GMI Research is a market research and consulting company that offers business insights and market research reports for large and small & medium enterprises. Our detailed reports help the clients to make strategic business policies and achieve sustainable growth in the particular market domain. The company’s large team of seasoned analysts and industry experts with experience from different regions such as Asia-Pacific, Europe, North America, among others, provides a one-stop solution for the client. Our market research report has in-depth analysis, which includes refined forecasts, a bird’s eye view of the competitive landscape, key factors influencing the market growth, and various other market insights to aid companies in making strategic decisions. Featured in the ‘Top 20 Most Promising Market Research Consultants’ list of Silicon India Magazine in 2018, we at GMI Research are always looking forward to helping our clients to stay ahead of the curve.
Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website: www.gmiresearch.com
